XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 99 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,139,000 | -37.9% | 465,049 | +3.2% | 0.02% | -35.3% |
| Q2 2021 | $1,833,000 | -6.3% | 450,414 | +3.9% | 0.03% | -17.1% |
| Q1 2021 | $1,956,000 | +27.2% | 433,710 | +38.7% | 0.04% | +17.1% |
| Q4 2020 | $1,538,000 | -25.1% | 312,590 | -9.8% | 0.04% | -50.0% |
| Q3 2020 | $2,054,000 | +127.0% | 346,428 | +1.8% | 0.07% | +112.1% |
| Q2 2020 | $905,000 | -35.5% | 340,403 | +312.6% | 0.03% | -66.7% |
| Q4 2018 | $1,403,000 | -39.2% | 82,504 | -37.1% | 0.10% | -20.8% |
| Q3 2018 | $2,306,000 | -7.1% | 131,145 | +0.3% | 0.12% | -16.1% |
| Q2 2018 | $2,481,000 | – | 130,700 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 3,661,237 | $14,901,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,553,398 | $26,672,000 | 0.47% |
| Alpine Global Management, LLC | 354,524 | $1,443,000 | 0.20% |
| DELTEC ASSET MANAGEMENT LLC | 275,500 | $1,121,000 | 0.15% |
| Kamunting Street Capital Management, L.P. | 67,594 | $275,000 | 0.11% |
| IHT Wealth Management, LLC | 340,147 | $1,384,000 | 0.09% |
| Redmile Group, LLC | 1,358,825 | $5,530,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 173,318 | $705,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,815,091 | $7,387,000 | 0.06% |
| GPS Wealth Strategies Group, LLC | 49,025 | $200,000 | 0.05% |